<DOC>
	<DOCNO>NCT01097551</DOCNO>
	<brief_summary>The aim study progress understand early retinal vascular neural abnormality patient diabetes , use new device , Dynamic Vessel Analyzer . The Dynamic Vessel Analyzer allow measure diameter retinal vessel assess varies presence various stimulus . Then , able ass vascular and/or neural dysfunction present early patient diabetes .</brief_summary>
	<brief_title>Endothelial Dysfunction Diabetes</brief_title>
	<detailed_description>Twenty patient type 1 diabetes without diabetic retinopathy without arterial hypertension compare 20 sex aged-matched healthy control subject . To assess presence retinal endothelial dysfunction , variation diameter retinal vessel assess use Dynamic Vessel Analyzer , flicker light stimulation , sublingual nitroglycerin , neosynephrine eyedrop , isometric contraction . To assess presence peripheral endothelial dysfunction , microcirculation forearm skin study use iontophoresis acetylcholine delivery , heat delivery , couple blood flow measurement use laser Doppler . An intravital capillaroscopy phalanx skin perform . The serum level CRP , ICAM-1 , VCAM-1 , VEGF , angiopoietin 2 endostatin also measure .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<mesh_term>Acetylcholine</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<criteria>For diabetic patient : age 20 60 type 1 diabetes mellitus diabetes duration 5 year diabetic retinopathy fundus examination fundus photograph systemic hypertension ( define systolic blood pressure &gt; 140 mmHg , diastolic blood pressure &gt; 90 mmHg ) For control subject : sex age matching diabetic patient diabetes , familial personal history elevate blood sugar Nondiabetic subject , criterion define fast glucose &lt; 1.10 g / l HbA1c &lt; 6.5 % ( accord Lariboisi√®re biochemistry laboratory HbA1c ) systemic hypertension ( define systolic blood pressure &gt; 140 mmHg , diastolic blood pressure &gt; 90 mmHg ) Subject normal ophthalmologic examination For diabetic patient control subject : Subject sign informed consent Subject affiliate social security Subject available period 4 month For diabetic patient control subject : presence cataract history cataract surgery intraocular pressure 21 mmHg treatment vasoactive drug tobacco consumption 20 cigarette day Contraindications trinitrin administration : hypersensitivity trinitrin , treatment sildenafil , heart disease , severe arterial hypotension , bradycardia , intracranial hypertension Clinical Raynaud syndrome Pregnant breastfeeding subject Subject whose age &lt; 18 &gt; 60 year day inclusion Subject cardiac disease , severe hypotension ( BP &lt; 80/50 mmHg ) , rest heart rate 50 beat / minute Subject intracranial hypertension Subject current consumption drug drug may impact vasomotion ( antiglaucoma eye drop , vasodilator , antihypertensive drug ) . Vasoactive drug use prohibit within 24 hour precede study . Subject sign informed consent Subject affiliate social security Subject available period 4 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Type 1 diabetes mellitus</keyword>
	<keyword>Diabetic retinopathy</keyword>
	<keyword>Pathogenesis</keyword>
	<keyword>Dynamic Vessel Analyser</keyword>
	<keyword>Endothelial dysfunction</keyword>
</DOC>